CASIN

CAS No. 425399-05-9

CASIN ( CASIN )

Catalog No. M17507 CAS No. 425399-05-9

CASIN is a specific inhibitor of GTPase Cdc42 (IC50: 2 uM).

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 41 In Stock
5MG 61 In Stock
10MG 111 In Stock
25MG 178 In Stock
50MG 267 In Stock
100MG 412 In Stock
500MG 888 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CASIN
  • Note
    Research use only, not for human use.
  • Brief Description
    CASIN is a specific inhibitor of GTPase Cdc42 (IC50: 2 uM).
  • Description
    CASIN is an inhibitor of Cdc42 GTPase, a small GTPase of the Rho-subfamily that plays important roles in cytoskeleton organization, cell cycle progression, signal transduction, and vesicle trafficking. CASIN generated a rejuvenated phenotype of Hematopoietic stem cells (HSCs), reversing the aging-related and polarity phenotype of aged HSCs to that of young HSCs in vivo.
  • Synonyms
    CASIN
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    STAT3
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    425399-05-9
  • Formula Weight
    306.41
  • Molecular Formula
    C20H22N2O
  • Purity
    98%
  • Solubility
    DMSO : ≥ 31 mg/mL; 101.17 mM
  • SMILES
    C1CC(c2c(C1)c1c([nH]2)ccc(c1)c1ccccc1)NCCO
  • Chemical Name
    2-[(2,3,4,9-Tetrahydro-6-phenyl-1H-carbazol-1-yl)amino]ethanol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li Y,et al. Suppression of cancer relapse and metastasis by inhibiting cancer stemness. Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1839-44.
molnova catalog
related products
  • Cyclo(-RGDfK) TFA

    Cyclo(-RGDfK) is a selective αvβ3 integrin inhibitor(IC50 : 0.94 nM).

  • RUC-4

    A potent, selective, non-RGD-mimetic αIIbβ3 integrin receptor antagonist with IC50 of 45 nM, with no activity on αVβ3 receptors.

  • BIO-5192

    A potent, highly selective inhibitor of integrin α4β1 (VLA-4) with Kd of <10 pM, IC50 of 1.8 nM.